Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: ClofarabineSponsors: Dana-Farber Cancer Institute; Sanofi; St. Baldrick's Foundation; Cookies for kids cancer foundationNot yet recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Histiocytosis | Langerhans Cell Histiocytosis (LCH) | Research | Study